Raymond James Trust N.A. Viatris Inc Transaction History
Raymond James Trust N.A.
- $4.22 Billion
- Q2 2024
A detailed history of Raymond James Trust N.A. transactions in Viatris Inc stock. As of the latest transaction made, Raymond James Trust N.A. holds 34,458 shares of VTRS stock, worth $410,050. This represents 0.01% of its overall portfolio holdings.
Number of Shares
34,458
Previous 42,164
18.28%
Holding current value
$410,050
Previous $503,000
27.24%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding VTRS
# of Institutions
1,100Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.67 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.1 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$739 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$685 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$676 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14.4B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...